| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0003062> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0013218> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0021242> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0034693> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0034721> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0035363> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0086893> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0254211> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0292818> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0674432> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0674433> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0678152> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0687133> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C0733594> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C1110556> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C2713498> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C2717829> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C5399815> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C5435317> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C5435318> <https://research.tib.eu/covid-19/entity/34269012_HAS_TOPIC_C5435319>
?:authorAffiliation	[\'Department of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.\', \'Public Service Platform for the Evaluation of Innovative Drug Property, Hangzhou 311121, China.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Hu_Yunzhen> <https://research.tib.eu/covid-19/entity/Jiang_Saiping> <https://research.tib.eu/covid-19/entity/Li_Lu> <https://research.tib.eu/covid-19/entity/Lu_Xiaoyang> <https://research.tib.eu/covid-19/entity/Wang_Rongrong> <https://research.tib.eu/covid-19/entity/Wang_Xiaojuan> <https://research.tib.eu/covid-19/entity/Zuo_Minjuan>
?:doi	1673-1581(2021)07-0599-0410.1631/jzus.B2000728
?:doi	<https://research.tib.eu/covid-19/entity/1673-1581%282021%2907-0599-0410.1631/jzus.B2000728>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Journal of Zhejiang University. Science. B
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34269012>
?:pmid	<https://research.tib.eu/covid-19/entity/34269012>
?:pmid	34269012
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Pharmacokinetic interactions between the potential COVID-19 treatment drugs lopinavir/ritonavir and arbidol in rats.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34269012>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34269012>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all